Intuitive (NASDAQ: ISRG) announced that the FDA cleared its da Vinci single port (SP) surgical robot for use in new types of ...

In the past quarter, Intuitive Surgical reported stronger-than-expected results, with revenue and earnings surpassing ...

The da Vinci SP system enables surgeons to perform procedures through a single incision or natural orifice, offering enhanced visualization and precision. Its design supports access to anatomy by ...

Intuitive announced that the FDA has cleared the da Vinci Single Port surgical system for use in inguinal hernia repair, cholecystectomy, and ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

SHANGHAI, CHINA - NOVEMBER 06 2022: The Da Vinci Surgical System, manufactured by Intuitive Surgical, demonstrate its capabilities at the China International Import Expo in Shanghai, China Sunday, Nov ...

Intuitive Surgical (NASDAQ: ISRG) has rewarded long-term investors by climbing nearly 200% over the past five years. This is thanks to the company's leadership in a hot growth area: robotic surgery.

Intuitive Surgical's business starts with the sale of a da Vinci surgical robot, but that's not where it ends.

Intuitive Surgical (NASDAQ: ISRG) has seen solid gains of over 80% from levels of around $270 in early January 2021 to nearly $500 now, vs. an increase of about 50% for the S&P 500 over this period.

The stock has lagged broader equities this year, but patient investors who initiate positions today might be very well ...